Skip to main content

Table 3 Predictors of overall survival (Cox-hazard test)

From: Long-term survival rates of patients with nasopharyngeal carcinoma treated by radiochemotherapy: a retrospective cohort study

 

P value

Exp(B)

95.0% CI for Exp(B)

Lower

Upper

Age

.195

1.038

.981

1.099

Sex

.400

1.963

.408

9.448

T Stage

 T1 (reference)

.155

   

 T2

.522

1.883

.271

13.065

 T3

.115

.247

.044

1.405

 T4

.850

1.215

.161

9.185

N Stage

 N0 (reference)

.445

   

 N1

.170

.162

.012

2.177

 N2

.223

.228

.021

2.456

 N3

.837

.821

.125

5.386

Induction ChTa

.463

.625

.178

2.191

Receiving Planned RT dose (70Gy)

.093

3.675

.805

16.772

Receiving Planned ChT Cyclesb

.025

6.351

1.268

31.815

Duration of RT

.831

1.007

.948

1.069

Locoregional recurrence

.025

.157

.031

.796

Distant metastasis

.000

.014

.002

.107

  1. aChemotherapy
  2. bTwo 3-weekly or 6-weekly cisplatin